Suppression of interleukin-2 by the putative endogenous cannabinoid 2- arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells

Molecular Pharmacology

Volumn 53, Issue 4, 1998, Pages 676-683

  Ouyang, Yanli ^a   Hwang, Seong Gu ^a   Han, Seung Hyun ^a   Kaminski, Norbert E ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABINOID RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; INTERLEUKIN 2; MESSENGER RNA; NUCLEAR FACTOR; PHORBOL 13 ACETATE 12 MYRISTATE; RECEPTOR SUBTYPE;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; DOWN REGULATION; ELECTROPHORETIC MOBILITY; FEMALE; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION;

EID: 2642609451     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.53.4.676     Document Type: Article

References (40)

1. Baeuerle PA and Henkel T (1994) Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141-179.
2. Barg J, Fride E, Hanus L, Levy R, Matus-Leibovitch N, Heldman E, Bayewitch M, Mechoulam R, and Vogel Z (1995) Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamides. Eur J Pharmacol 287:145-152.
3. Barton K, Muthusamy N, Chanyangam M, Fischer C, Clendenin C, and Leiden JM (1996) Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB. Nature (Lond) 379:81-85.
4. Bisogno T, Sepe N, Melck D, Maurelli S, De Petrocellis L, and Di Marzo V (1997) Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells. Biochem J 322: 671-677.
5. Chen D and Rothenberg E (1993) Molecular basis for developmental changes in interleukin-2 gene inducibility. Mol Cell Biol 13:228-237.
6. Condie RC, Herring A, Koh WS, Lee M, and Kaminski NE (1996) Cannabinoid inhibition of adenylate cyclase-mediated signal transduction and IL-2 expression in the murine T-cell line, EL4. IL-2. J Biol Chem 271:13175-13183.
7. Crabtree GR and Clipstone NA (1994) Signal transmission between the plasma membrane and nucleus of T lymphocytes. Annu Rev Biochem 63:1045-1083.
8. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, and Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (Washington DC) 258:1946-1949.
9. Facci L, Dal Toso R, Romanello S, Buriani A, Skaper D, and Leon A (1995) Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA 92:3376-3380.
10. Felder CC, Briley EM, Axelrod J, Simpson JT, Mackie K, and Devane WA (1993) Anandamide, an endogenous cannabinomimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc Natl Acad Sci USA 90:7656-7660.
11. Felder CC, Joyce K, Briley E, Mansouri J, Mackie K, Blond O, Lai Y, Ma A, and Mitchell R (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 48:443-450.
12. Francis DA, Karras JG, Ke XY, Sen R, and Rothstein TL (1995) Induction of the transcription factors NF-κB, AP-1 and NF-AT during B cell stimulation through the CD40 receptor. Int Immunol 7:151-161.
13. Gilliland G, Perrin S, Blanchard K, and Bunn HF (1990) Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci USA 87:2725-2729.
14. Herring AC, Koh WS, and Kaminski NE (in press) The minimally CNS active cannabinoid, cannabinol, inhibits CRE and κB DNA binding in mouse leukocytes. Biochem Pharmacol.
15. Howlett AC (1995) Pharmacology of cannabinoid receptors. Annu Rev Pharmacol Toxicol 35:607-634.
16. i in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol Pharmacol 29:307-313.
17. Jain J, Loh C, and Rao A (1995) Transcriptional regulation of the IL-2 gene. Curr Opin Immunol 7:333-342.
18. Jain J, Miner Z, and Rao A (1993) Analysis of the preexisting and nuclear forms of nuclear factor of activated T cells. J Immunol 151:837-848.
19. Kaminski NE (1996) Immune regulation by cannabinoid compounds through the inhibition of the cyclic AMP signaling cascade and altered gene expression. Biochem Pharm 52:1133-1140.
20. Kaminski NE, Abood ME, Kessler FK, Martin BR, and Schatz AR (1992) Identification of a functionally relevant cannabinoid receptor on mouse spleen cells involved in cannabinoid-mediated immune modulation. Mol Pharmacol 42:736-742.
21. Kaminski NE, Koh WS, Lee M, Yang KH, and Kessler FK (1994) Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism. Biochem Pharm 48:1899-1908.
22. 9-Tetrahydrocannabinol inhibits the activation and binding of CRE-specific transcription factors: a putative mechanism of cannabinoid-induced immune modulation. Biochem Pharm 53:1477-1484.
23. Lee M, Yang KH, and Kaminski NE (1995) Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes. J Pharmacol Exp Ther 275:529-536.
24. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, and Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564.
25. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, Pertwee RG, Griffin G, Bayewitch M, Barg J, and Vogel Z (1995) Identification of an endogenous 2-monoglyceride present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83-90.
26. Munro S, Thomas KL, and Abu-Shaar M (1993) Molecular characterization of peripheral receptor for cannabinoids. Nature (Lond) 365:61-65.
27. + T cells. Toxicology 104:187-202.
28. Petrak D, Memon SA, Birrer MJ, Ashwell JD, and Zacharchuk CM (1994) Dominant negative mutant of c-Jun inhibits NF-AT transcriptional activity and prevents IL-2 gene transcription. J Immunol 153:2046-2051.
29. Phipps RP, Stein SH, and Roper RL (1991) A new view of prostaglandin E regulation of the immune response. Immunol Today 12:349-352.
30. Pierce JW, Lenardo M, and Baltimore D (1988) Oligonucleotide that binds nuclear factor NF-κB acts as a lymphoid-specific and inducible enhancer element. Proc Natl Acad Sci USA 85:1482-1486.
31. Priller J, Briley EM, Mansouri J, Devane WA, Mackie K, and Felder CC (1995) Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors. Mol Pharmacol 48:288-292.
32. 9-tetrahydrocannabinol in mouse spleen cells: a potential mechanism for cannabinoid-mediated immunosuppression. Life Sci 51:25-30.
33. Schatz AR, Lee M, Condie R, Pulaski J, and Kaminski NE (1997) Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol Appl Pharmacol 142:278-287.
34. Shivachar AC, Martin BR, and Ellis EF (1996) Anandamide-and delta 9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methy-IH- pyrazole-3-carboximide hydrochloride]. Biochem Pharmacol 51:669-676.
35. Smith K (1988) A. Interleukin-2: inception, impact and implications. Science (Washington DC) 240:1169-1176.
36. Stella N, Schweitzer P, and Piomelli D (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature (Lond) 388:773-778.
37. +2 in neuroblastoma X glioma hybrid NG108-15 cells. Biochem Biophys Res Commun 229:58-64.
38. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, and Waku K (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215:89-97.
39. Wartmann M, Cambell D, Subramanian A, Burnstein SH, and Davis RJ (1995) The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide. FEBS Lett 359:133-136.
40. Yebra M, Klein TW, and Friedman H (1992) Delta-9-tetrahydrocannabinol suppresses concanavalin A induced increase in cytoplasmic free calcium in mouse thymocytes. Life Sci 51:151-160.